We validated the upregulation of BAP1 mRNA levels in an independent University of Hong Kong-Queen Mary Hospital (HKU-QMH) cohort comprising 124 HCC cases using qRT-PCR. The gene discussed is BAP1; the disease is hepatocellular carcinoma.